The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans.
Barve A, Kovacs SJ, Ke J, Crabbe R, Grosgurin P, Menetrey A, Nicolas-Métral V, Dabovic K, Dole K, Zhang J, Praestgaard J, Sunkara G, Stein D.
Barve A, et al. Among authors: crabbe r.
Clin Pharmacol Drug Dev. 2015 Jan;4(1):25-32. doi: 10.1002/cpdd.114. Epub 2014 May 26.
Clin Pharmacol Drug Dev. 2015.
PMID: 27128001
Clinical Trial.